Oncimmune Holdings PLC | Income Statement
Fiscal year is June-May. All values GBP Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
1,057.00
1,345.00
430.00
215.00
240
Cost of Goods Sold (COGS) incl. D&A
141.00
44.00
147.00
532.00
1,097
Gross Income
916.00
1,301.00
283.00
317.00
857
SG&A Expense
3,671.00
2,683.00
4,771.00
4,956.00
5,517
EBIT
2,755.00
1,382.00
4,488.00
5,273.00
6,374
Unusual Expense
-
-
3,788.00
-
-
Non Operating Income/Expense
1,336.00
-
-
-
-
Interest Expense
350.00
646.00
737.00
69.00
16
Pretax Income
1,593.00
2,013.00
9,008.00
5,316.00
6,342
Income Tax
181.00
-
566.00
293.00
-
Consolidated Net Income
1,412.00
2,013.00
8,442.00
5,023.00
6,342
Net Income
1,412.00
2,013.00
8,442.00
5,023.00
6,342
Net Income After Extraordinaries
1,412.00
2,013.00
8,442.00
5,023.00
6,342
Net Income Available to Common
1,412.00
2,013.00
8,442.00
5,023.00
6,342
EPS (Basic)
0.03
0.04
0.24
0.10
0.11
Basic Shares Outstanding
51,024.40
51,024.40
35,866.40
51,024.40
55,558.20
EPS (Diluted)
0.03
0.04
0.24
0.10
0.11
Diluted Shares Outstanding
51,024.40
51,024.40
35,866.40
51,024.40
55,558.20
EBITDA
2,714.00
1,341.00
4,410.00
5,182.00
6,194
Non-Operating Interest Income
176.00
15.00
5.00
26.00
48
About Oncimmune Holdings
View Profile
